A prostate cancer diagnosis usually brings a stack of decisions at once: which treatment path fits the stage and grade of the disease, which hospital has the right mix of surgical and radiation expertise, and how it all gets paid for. Treatment ranges from simply monitoring a slow-growing tumor to combining surgery, radiation, and newer targeted therapies, so the “best” hospital often depends on what stage a patient is at and what kind of care team they need.
This guide covers ten U.S. hospitals with established prostate cancer and urologic oncology programs, plus a plain-English look at treatment options, typical costs, and how Medicare and private insurance tend to handle this disease. It’s a starting point for research and conversations with your own care team, not a substitute for either.
How These Hospitals Were Selected
These hospitals are drawn primarily from U.S. News & World Report’s cancer care rankings for 2025–2026, which weigh risk-adjusted patient outcomes, nursing care, and performance on complex cases rather than routine ones. A few are included for well-documented specialty strengths, such as surgical volume or research infrastructure, even where a numbered rank wasn’t the deciding factor. Where a hospital describes itself as “world-class” or “leading,” we’ve treated that as the hospital’s own characterization, not an independently verified fact.
Quick Comparison
| Hospital | Location | Key Strength | Notable For |
|---|---|---|---|
| MD Anderson Cancer Center | Houston, TX | Oncology depth | Long-standing #1 U.S. News cancer ranking |
| Memorial Sloan Kettering | New York, NY | Specialist scale | Over 15,000 specialists across subspecialties |
| Dana-Farber Brigham Cancer Center | Boston, MA | Precision medicine | Localized and targeted treatment planning |
| Mayo Clinic | Rochester, MN | Integrated urology care | High patient volume, multidisciplinary teams |
| Massachusetts General Hospital | Boston, MA | Unified cancer institute | Merged program with Brigham and Women’s |
| Cleveland Clinic | Cleveland, OH | Robotic surgery | Pioneering urologic surgical techniques |
| Johns Hopkins Hospital | Baltimore, MD | Surgical expertise | Home of the Brady Urological Institute |
| UCLA Medical Center | Los Angeles, CA | Radiation therapy | Strong outcomes in targeted radiation |
| University of Chicago Medical Center | Chicago, IL | Clinical trials | Individualized treatment protocols |
| Northwestern Memorial Hospital | Chicago, IL | Regional leadership | Comprehensive Midwest urologic oncology program |
1. MD Anderson Cancer Center — Houston, Texas
MD Anderson has held the top spot in U.S. News’s cancer rankings for well over a decade, and prostate cancer care is one of the areas keeping it there. Patients typically have access to everything from active surveillance for low-risk disease to advanced radiation and systemic therapies for cancer that has spread. High case volume tends to translate into more experience with unusual or complicated presentations.
2. Memorial Sloan Kettering Cancer Center — New York, New York
MSK operates with more than 15,000 specialists across its network — depth that matters for prostate cancer, since accurate staging can change the entire treatment plan. That scale often means faster access to subspecialists in pathology, radiology, and genetics who can refine a diagnosis before treatment begins.
3. Dana-Farber Brigham Cancer Center — Boston, Massachusetts
Run jointly with Brigham and Women’s Hospital, Dana-Farber has a strong reputation in precision medicine — treatment decisions guided by a tumor’s specific genetic and molecular features rather than a standard protocol. For prostate cancer, this can influence whether a patient is a good candidate for active surveillance versus earlier intervention.
4. Mayo Clinic — Rochester, Minnesota
Mayo’s urology program handles a large volume of prostate cancer cases annually and leans heavily on multidisciplinary care: urologists, radiation oncologists, and medical oncologists typically weigh in together on complex cases rather than a patient moving between separate specialists. Patients researching Mayo often cite this coordination as a reason to consider a second opinion there, even when primary treatment happens closer to home.
5. Massachusetts General Hospital — Boston, Massachusetts
Mass General has climbed recent national cancer rankings after unifying its cancer institute with Brigham and Women’s Hospital, a merger hospital officials say has improved coordination and inpatient outcomes. For prostate cancer patients, that structure can mean easier access to clinical trials and research-driven treatment within a single system.
6. Cleveland Clinic — Cleveland, Ohio
Cleveland Clinic has a national reputation in urologic surgery, particularly robotic-assisted prostatectomy. Robotic techniques let surgeons work through smaller incisions with more precise control, which can reduce blood loss and, in some cases, better preserve nerves involved in urinary and sexual function. Patients weighing surgery often look at a hospital’s volume and technique before deciding.
7. Johns Hopkins Hospital — Baltimore, Maryland
Johns Hopkins is home to the Brady Urological Institute, credited with developing the nerve-sparing prostatectomy technique now standard at many hospitals. It draws prostate cancer patients from across the country, reflecting both its academic reputation and high surgical case volume.
8. UCLA Medical Center — Los Angeles, California
UCLA has a strong track record in radiation-based prostate cancer treatment, including advanced targeted approaches. For patients who aren’t surgical candidates, or who prefer to avoid surgery, a program’s access to newer technologies like stereotactic body radiotherapy can be a deciding factor.
9. University of Chicago Medical Center — Chicago, Illinois
This program is known for running a substantial number of active clinical trials and building individualized protocols rather than defaulting to a standard regimen. Patients interested in newer therapies, including the radioligand treatment discussed below, may find that access to ongoing trials is a meaningful reason to seek a consultation here.
10. Northwestern Memorial Hospital — Chicago, Illinois
Northwestern offers a comprehensive urologic oncology program serving the greater Chicago area and broader Midwest, with the full range of standard options from surveillance through surgery and radiation. Its cancer program is regularly recognized in regional and national quality assessments.
Treatment Options Explained
Active surveillance. For slow-growing, low-risk cancers, doctors may recommend regular PSA tests, physical exams, and periodic biopsies instead of immediate treatment, since some prostate cancers grow so slowly they may never require intervention.
Surgery (radical prostatectomy). Removal of the prostate gland, often using robotic-assisted techniques that allow smaller incisions and more precise nerve-sparing than open surgery.
Radiation therapy. Includes external beam radiation (EBRT), stereotactic body radiotherapy (SBRT/CyberKnife), proton beam therapy, and brachytherapy, where radioactive seeds are placed directly in the prostate. Each carries a different timeline and side-effect profile.
Hormone therapy (androgen deprivation therapy). Since prostate cancer cells generally rely on testosterone to grow, reducing hormone levels can slow or shrink tumors. It’s often paired with radiation or used in advanced disease.
Radioligand therapy. 177Lu-PSMA-617 (Pluvicto) is an FDA-approved treatment for metastatic castration-resistant prostate cancer. It targets PSMA, a protein overexpressed on many prostate cancer cells, delivering a localized radiation dose directly to them. Phase III trials have shown meaningful survival improvements for appropriate candidates, though it’s intended for advanced disease, not early-stage cancer.
Chemotherapy and immunotherapy. Generally reserved for cancer that has spread beyond the prostate and stopped responding to hormone therapy. Sipuleucel-T (Provenge) is a notable immunotherapy option, custom-made from a patient’s own immune cells.
What Treatment Tends to Cost
Costs vary by stage, treatment type, hospital, and geography, so the figures below are general ranges, not quotes for any individual patient.
| Treatment or Stage | General Cost Range | Notes |
|---|---|---|
| Early-stage, first year of care | $28,000–$30,000 | Includes diagnostics and primary treatment |
| Radical prostatectomy | $20,000–$40,000 | Varies with hospital fees and robotic vs. open technique |
| Radiation therapy | $25,000–$45,000 | Proton beam therapy tends toward the higher end |
| Advanced or late-stage care | $50,000–$100,000+ | Complex metastatic care can average roughly $74,000 annually |
Ongoing management adds up beyond initial treatment: some cost studies put average monthly out-of-pocket costs after diagnosis at around $2,800, driven largely by follow-up visits, imaging, and recovery-related care.
Medicare, Insurance, and a Common Misunderstanding
Many men assume prostate cancer screening is entirely free under Medicare — that’s only partly true. Medicare Part B covers one PSA blood test per year at no cost, but the accompanying digital rectal exam is billed separately, leaving patients responsible for the Part B deductible and 20% coinsurance on that portion.
It gets more complicated after an abnormal result. Once a PSA test comes back elevated, follow-up testing — a repeat PSA, an MRI, a biopsy — is reclassified from “preventive” to “diagnostic,” which means it’s subject to the deductible and coinsurance in a way the annual screening test isn’t.
Private insurance generally covers standard treatments too, but deductibles, copayments, and network status can still leave patients with substantial bills. Newer therapies like radioligand treatment often require prior authorization and get billed as specialty drugs, which typically carry higher cost-sharing. Confirm specifics directly with your insurer and the hospital’s billing office before starting treatment.
What to Consider When Choosing a Hospital
- Experience of the hospital and specific surgical or radiation team with your stage of prostate cancer
- Whether the hospital is in your insurance network, and what that means for out-of-pocket costs
- Access to clinical trials, particularly for newer options like radioligand therapy
- Distance from home, since treatment often involves months of follow-up visits
- A multidisciplinary team, so urology, radiation oncology, and medical oncology coordinate rather than working in isolation
Frequently Asked Questions
How much does prostate cancer treatment cost in the U.S.? Early-stage care often runs $28,000–$30,000 for the first year; advanced disease can push past $50,000 annually. Insurance significantly affects actual out-of-pocket costs.
Does Medicare cover prostate cancer screening for free? Only partially. The annual PSA blood test is free under Medicare Part B, but the digital rectal exam and any follow-up diagnostic testing after an abnormal result are subject to the deductible and 20% coinsurance.
What is Pluvicto, and who is it for? A radioligand therapy approved for metastatic castration-resistant prostate cancer. It targets a protein on cancer cells to deliver localized radiation and has shown improved survival in clinical trials, but it’s for advanced disease, not early-stage diagnoses.
Is surgery always necessary for prostate cancer? No. Many low-risk, slow-growing cases are managed with active surveillance. The right approach depends on grade, stage, and behavior over time — a decision made with a urologist or oncologist.
How do I choose between a hospital known for surgery versus one known for radiation? It often comes down to your diagnosis, personal preferences around side effects and recovery, and your care team’s recommendation. A second opinion at a center strong in both areas can help before deciding.
Will my insurance cover newer treatments like radioligand therapy? Often yes, but typically with prior authorization and higher specialty-tier copays. Check directly with your insurer before assuming coverage.
Before scheduling treatment, confirm the hospital’s experience with your specific procedure, ask for a detailed cost estimate, and verify insurance coverage directly with your provider.
Sources
- U.S. News & World Report, Best Hospitals for Cancer Rankings, 2025–2026
- Centers for Medicare & Medicaid Services (CMS), Medicare Part B coverage guidelines
- U.S. Food and Drug Administration, Pluvicto (177Lu-PSMA-617) approval information
- Published Phase III clinical trial data (VISION and PSMAfore trials) on radioligand therapy outcomes
Medical Disclaimer
This article is for general informational and educational purposes only and does not constitute medical advice. Hospital rankings, programs, and treatment availability can change over time, and costs and insurance coverage vary based on individual circumstances, location, and plan details. Readers should verify current information with hospitals, insurers, and qualified healthcare professionals before making treatment decisions. If you are experiencing a medical emergency, seek immediate professional medical attention.
1 thought on “10 Best Hospitals for Prostate Cancer Treatment in the USA: Cost, Insurance & Treatment Options”